Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 517

1.

Proton Pump Inhibitor Induction of Gastric Cobblestone-like Lesions in the Stomach.

Takahari K, Haruma K, Ohtani H, Kiyoto S, Watanabe A, Kamada T, Manabe N, Hatano Y.

Intern Med. 2017 Sep 15. doi: 10.2169/internalmedicine.7964-16. [Epub ahead of print]

2.

Design paper: Japan Endoscopy Database (JED): a prospective, big database project related to Gastroenterological Endoscopy in Japan.

Matsuda K, Tanaka K, Fujishiro M, Saito Y, Ohtsuka K, Oda I, Katada C, Kato M, Kida M, Kobayashi K, Hoteya S, Horimatsu T, Kodashima S, Matsuda T, Muto M, Yamamoto H, Ryozawa S, Iwakiri R, Kutsumi H, Miyata H, Kato M, Haruma K, Fujimoto K, Uemura N, Kaminishi M, Tajiri H.

Dig Endosc. 2017 Sep 14. doi: 10.1111/den.12964. [Epub ahead of print]

PMID:
28905472
3.

First progress report on the Japan Endoscopy Database (JED) project.

Kodashima S, Tanaka K, Matsuda K, Fujishiro M, Saito Y, Ohtsuka K, Oda I, Katada C, Kato M, Kida M, Kobayashi K, Hoteya S, Horimatsu T, Matsuda T, Muto M, Yamamoto H, Ryozawa S, Iwakiri R, Kutsumi H, Miyata H, Kato M, Haruma K, Fujimoto K, Uemura N, Kaminishi M, Tajiri H.

Dig Endosc. 2017 Sep 8. doi: 10.1111/den.12963. [Epub ahead of print]

PMID:
28885724
4.

Significance of measurement of serum trough level and anti-drug antibody of adalimumab as personalised pharmacokinetics in patients with Crohn's disease: a subanalysis of the DIAMOND trial.

Nakase H, Motoya S, Matsumoto T, Watanabe K, Hisamatsu T, Yoshimura N, Ishida T, Kato S, Nakagawa T, Esaki M, Nagahori M, Matsui T, Naito Y, Kanai T, Suzuki Y, Nojima M, Watanabe M, Hibi T; DIAMOND study group.

Aliment Pharmacol Ther. 2017 Sep 8. doi: 10.1111/apt.14318. [Epub ahead of print]

PMID:
28884856
5.

New ultrasonographic screening method for oropharyngeal dysphagia : Tissue Doppler imaging.

Manabe N, Haruma K, Nakato R, Kusunoki H, Kamada T, Hata J.

Am J Physiol Gastrointest Liver Physiol. 2017 Sep 1:ajpgi.00019.2017. doi: 10.1152/ajpgi.00019.2017. [Epub ahead of print]

PMID:
28864498
6.

Early Intervention with Infliximab Prevents Reoperation in Crohn's Disease: A Single-Center Retrospective Analysis.

Ishii M, Tarumi KI, Shiotani A, Kamada T, Fujita M, Matsumoto H, Murao T, Manabe N, Kusunoki H, Hata J, Haruma K.

Digestion. 2017 Sep 1;96(3):158-165. doi: 10.1159/000480078. [Epub ahead of print]

PMID:
28858864
7.

Development and validation of a simple and multifaceted instrument, GERD-TEST, for the clinical evaluation of gastroesophageal reflux and dyspeptic symptoms.

Nakada K, Matsuhashi N, Iwakiri K, Oshio A, Joh T, Higuchi K, Haruma K.

World J Gastroenterol. 2017 Jul 28;23(28):5216-5228. doi: 10.3748/wjg.v23.i28.5216.

8.

Clinical characteristics and associated factors of Japanese patients with adenocarcinoma of the esophagogastric junction: a multicenter clinicoepidemiological study.

Matsueda K, Manabe N, Toshikuni N, Sato Y, Watanabe T, Yamamoto H, Haruma K.

Dis Esophagus. 2017 Jun 1;30(6):1-6. doi: 10.1093/dote/dox007.

PMID:
28475744
9.

Gender Differences in Serotonin Signaling in Patients with Diarrhea-predominant Irritable Bowel Syndrome.

Katsumata R, Shiotani A, Murao T, Ishii M, Fujita M, Matsumoto H, Haruma K.

Intern Med. 2017;56(9):993-999. doi: 10.2169/internalmedicine.56.7674. Epub 2017 May 1.

10.

Association between endoscopic findings related to colonic diverticula and bowel habits: a multicenter study in Japan.

Yamada E, Kuriyama H, Uchida E, Murata Y, Hata Y, Tagri M, Isozaki Y, Oyamada H, Ozawa Y, Ito T, Mizuki A, Inamori M, Manabe N, Haruma K, Nakajima A.

J Gastroenterol Hepatol. 2017 Apr 19. doi: 10.1111/jgh.13805. [Epub ahead of print]

PMID:
28425144
11.

Effects of Capsaicin on Older Patients with Oropharyngeal Dysphagia: A Double-Blind, Placebo-Controlled, Crossover Study.

Nakato R, Manabe N, Shimizu S, Hanayama K, Shiotani A, Hata J, Haruma K.

Digestion. 2017;95(3):210-220. doi: 10.1159/000463382. Epub 2017 Mar 21.

PMID:
28319947
12.

Optimal dose of ramosetron in female patients with irritable bowel syndrome with diarrhea: A randomized, placebo-controlled phase II study.

Fukudo S, Matsueda K, Haruma K, Ida M, Hayase H, Akiho H, Nakashima Y, Hongo M.

Neurogastroenterol Motil. 2017 Jun;29(6). doi: 10.1111/nmo.13023. Epub 2017 Feb 16.

PMID:
28205278
13.

Tolerable pain reduces gastric fundal accommodation and gastric motility in healthy subjects: a crossover ultrasonographic study.

Hasuo H, Kusunoki H, Kanbara K, Abe T, Yunoki N, Haruma K, Fukunaga M.

Biopsychosoc Med. 2017 Feb 1;11:4. doi: 10.1186/s13030-017-0089-5. eCollection 2017.

14.

Factors associated with complicated erosive esophagitis: A Japanese multicenter, prospective, cross-sectional study.

Sakaguchi M, Manabe N, Ueki N, Miwa J, Inaba T, Yoshida N, Sakurai K, Nakagawa M, Yamada H, Saito M, Nakada K, Iwakiri K, Joh T, Haruma K.

World J Gastroenterol. 2017 Jan 14;23(2):318-327. doi: 10.3748/wjg.v23.i2.318.

15.

Age-Related Differences in Clinical Characteristics and Esophageal Motility in Patients with Dysphagia.

Nakato R, Manabe N, Kamada T, Matsumoto H, Shiotani A, Hata J, Haruma K.

Dysphagia. 2017 Jun;32(3):374-382. doi: 10.1007/s00455-016-9763-1. Epub 2016 Dec 2.

PMID:
27913915
16.

Black Spot, a Novel Gastric Finding Potentially Induced by Proton Pump Inhibitors.

Hatano Y, Haruma K, Ayaki M, Kamada T, Ohtani H, Murao T, Manabe N, Mori H, Masaki T, Shiotani A.

Intern Med. 2016;55(21):3079-3084. Epub 2016 Nov 1.

17.

Helicobacter pylori Eradication with Proton Pump Inhibitors or Potassium-Competitive Acid Blockers: The Effect of Clarithromycin Resistance.

Matsumoto H, Shiotani A, Katsumata R, Fujita M, Nakato R, Murao T, Ishii M, Kamada T, Haruma K, Graham DY.

Dig Dis Sci. 2016 Nov;61(11):3215-3220. Epub 2016 Sep 22.

PMID:
27659671
18.

Surveillance of patients with long-segment Barrett's esophagus: A multicenter prospective cohort study in Japan.

Matsuhashi N, Sakai E, Ohata K, Ishimura N, Fujisaki J, Shimizu T, Iijima K, Koike T, Endo T, Kikuchi T, Inayoshi T, Amano Y, Furuta T, Haruma K, Kinoshita Y.

J Gastroenterol Hepatol. 2017 Feb;32(2):409-414. doi: 10.1111/jgh.13491.

PMID:
27416773
19.

Randomized study of lafutidine vs lansoprazole in patients with mild gastroesophageal reflux disease.

Takenaka R, Okada H, Kawano S, Komazawa Y, Yoshinaga F, Nagata S, Inoue M, Komatsu H, Onogawa S, Kushiyama Y, Mukai S, Todo H, Okanobu H, Manabe N, Tanaka S, Haruma K, Kinoshita Y.

World J Gastroenterol. 2016 Jun 21;22(23):5430-5. doi: 10.3748/wjg.v22.i23.5430.

20.

Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.

Iwakiri K, Kinoshita Y, Habu Y, Oshima T, Manabe N, Fujiwara Y, Nagahara A, Kawamura O, Iwakiri R, Ozawa S, Ashida K, Ohara S, Kashiwagi H, Adachi K, Higuchi K, Miwa H, Fujimoto K, Kusano M, Hoshihara Y, Kawano T, Haruma K, Hongo M, Sugano K, Watanabe M, Shimosegawa T.

J Gastroenterol. 2016 Aug;51(8):751-67. doi: 10.1007/s00535-016-1227-8. Epub 2016 Jun 21. Review.

PMID:
27325300

Supplemental Content

Loading ...
Support Center